Literature DB >> 26719281

Preliminary comparison of normalized T1 and non-contrast perfusion MRI assessments of regional lung disease in cystic fibrosis patients.

Shannon B Donnola1, Elliott C Dasenbrook2, David Weaver3, Lan Lu4, Karishma Gupta1, Anjali Prabhakaran5, Xin Yu6, James F Chmiel3, Kimberly McBennett2, Michael W Konstan3, Mitchell L Drumm7, Chris A Flask8.   

Abstract

BACKGROUND: Previous studies have shown that Magnetic Resonance Imaging (MRI) techniques can be used to non-invasively assess lung disease in CF patients. In this study, we compare the sensitivity of normalized T1 (nT1) and non-contrast perfusion MRI techniques to detect regional lung disease in CF patients.
MATERIALS AND METHODS: MRI data were obtained for eight adult CF patients without overt pulmonary exacerbation (FEV1=45-127%) and six healthy volunteers on a Siemens Espree 1.5T MRI scanner. Sagittal nT1 and perfusion data were acquired for each subject's left and right lungs. A region-of-interest analysis was used to calculate mean nT1 and perfusion values in the individual lobes of the left and right lungs for each subject.
RESULTS: In comparison to healthy controls, CF subjects showed a significant decrease in nT1 values in the upper lobe of the left lung as well as in the upper and anterior lobes of the right lung (p<0.001). Similar nT1 differences were observed with in the CF cohort in comparison to their respective posterior lobes (p<0.001). Pulmonary perfusion for the CF subjects was also significantly reduced in the upper lobe of the right lung (p<0.05). Significant correlations with spirometry were also observed for both nT1 (left upper lobe: p<0.01) and perfusion (left and right upper lobes (p≤0.05)). Additionally, significant correlations were observed between nT1 and perfusion in the upper lobes of the left (p=0.05) and right lungs (p=0.005).
CONCLUSIONS: This pilot study confirms that both the nT1 and non-contrast perfusion MRI techniques can sensitively detect regional lung changes in patients with CF. While both imaging methods were able to detect regional lung disease, the additional nT1 reductions in the CF patients suggests that nT1 may be more sensitive to regional CF lung disease.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Imaging; Lung disease; Magnetic Resonance Imaging; Perfusion; Relaxometry

Mesh:

Year:  2015        PMID: 26719281      PMCID: PMC4916031          DOI: 10.1016/j.jcf.2015.11.009

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  28 in total

1.  MR perfusion imaging of pulmonary parenchyma using pulsed arterial spin labeling techniques: FAIRER and FAIR.

Authors:  V M Mai; S S Berr
Journal:  J Magn Reson Imaging       Date:  1999-03       Impact factor: 4.813

2.  Quantification of regional pulmonary blood flow using ASL-FAIRER.

Authors:  D S Bolar; D L Levin; S R Hopkins; L F Frank; T T Liu; E C Wong; R B Buxton
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

3.  Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.

Authors:  Claire E Wainwright; Suzanna Vidmar; David S Armstrong; Catherine A Byrnes; John B Carlin; Joyce Cheney; Peter J Cooper; Keith Grimwood; Marj Moodie; Colin F Robertson; Harm A Tiddens
Journal:  JAMA       Date:  2011-07-13       Impact factor: 56.272

4.  Quantitative evaluation of hyperpolarized helium-3 magnetic resonance imaging of lung function variability in cystic fibrosis.

Authors:  Miranda Kirby; Sarah Svenningsen; Hassaan Ahmed; Andrew Wheatley; Roya Etemad-Rezai; Nigel A M Paterson; Grace Parraga
Journal:  Acad Radiol       Date:  2011-05-04       Impact factor: 3.173

5.  Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease.

Authors:  Mark O Wielpütz; Michael Puderbach; Annette Kopp-Schneider; Mirjam Stahl; Eva Fritzsching; Olaf Sommerburg; Sebastian Ley; Migle Sumkauskaite; Jürgen Biederer; Hans-Ulrich Kauczor; Monika Eichinger; Marcus A Mall
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

6.  MR perfusion studies with T1-weighted echo planar imaging.

Authors:  K K Kwong; D A Chesler; R M Weisskoff; K M Donahue; T L Davis; L Ostergaard; T A Campbell; B R Rosen
Journal:  Magn Reson Med       Date:  1995-12       Impact factor: 4.668

7.  Inhaled hypertonic saline in infants and young children with cystic fibrosis.

Authors:  Elliott C Dasenbrook; Michael W Konstan
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

8.  The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Michael J Rock; Alan S Brody; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2011-12-13

9.  Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.

Authors:  Yvonne Belessis; Barbara Dixon; Glenn Hawkins; John Pereira; Jenny Peat; Rebecca MacDonald; Penny Field; Andrew Numa; John Morton; Kei Lui; Adam Jaffe
Journal:  Am J Respir Crit Care Med       Date:  2012-02-09       Impact factor: 21.405

10.  Computed tomography in the evaluation of cystic fibrosis lung disease.

Authors:  Alan S Brody; Harm A W M Tiddens; Robert G Castile; Harvey O Coxson; Pim A de Jong; Jonathan Goldin; Walter Huda; Frederick R Long; Michael McNitt-Gray; Michael Rock; Terry E Robinson; Scott D Sagel
Journal:  Am J Respir Crit Care Med       Date:  2005-08-11       Impact factor: 21.405

View more
  6 in total

1.  Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study.

Authors:  Jakub Lagan; Josephine H Naish; Christien Fortune; Christopher Campbell; Shien Chow; Manon Pillai; Joshua Bradley; Lenin Francis; David Clark; Anita Macnab; Gaetano Nucifora; Rebecca Dobson; Erik B Schelbert; Matthias Schmitt; Robert Hawkins; Christopher A Miller
Journal:  Diagnostics (Basel)       Date:  2022-05-30

Review 2.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

Review 3.  Novel imaging techniques for cystic fibrosis lung disease.

Authors:  Jennifer L Goralski; Neil J Stewart; Jason C Woods
Journal:  Pediatr Pulmonol       Date:  2021-02

4.  Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance.

Authors:  Jakub Lagan; Josephine H Naish; Joshua Bradley; Christien Fortune; Charlie Palmer; David Clark; Erik B Schelbert; Matthias Schmitt; Rowland Bright-Thomas; Christopher A Miller
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-07       Impact factor: 2.357

Review 5.  Lung function imaging methods in Cystic Fibrosis pulmonary disease.

Authors:  Magdalena Kołodziej; Michael J de Veer; Marian Cholewa; Gary F Egan; Bruce R Thompson
Journal:  Respir Res       Date:  2017-05-17

6.  Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with cardiopulmonary magnetic resonance.

Authors:  Jakub Lagan; Josephine H Naish; Christien Fortune; Joshua Bradley; David Clark; Robert Niven; Nazia Chaudhuri; Erik B Schelbert; Matthias Schmitt; Christopher A Miller
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-19       Impact factor: 2.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.